Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The randomized clinical treatment trial NCT06032988 - Bifidobacterium animalis lactis + Lactiplantibacillus plantarum + Lactobacillus acidophilus + Saccharomyces boulardii & Type 2 Diabetes (T2D) revealed that the administration of Bifidobacterium animalis lactis + Lactiplantibacillus plantarum + Lactobacillus acidophilus + Saccharomyces boulardii over a 6-month period in individuals with T2D was well-tolerated and had a positive impact on metabolic parameters, alongside improvements in indices of adiposity.
Zikou et al. 2023 Nutrients 15(21)…